22nd Century Expands Reduced-Nicotine Cigarette Lineup with 100mm VLN® Initiative

Event summary

  • 22nd Century completed prototyping and initial evaluations for a 100mm VLN® reduced-nicotine cigarette, advancing to regulatory submission phase.
  • The company plans to submit a second PMTA application for FDA authorization of the new 100mm VLN® product.
  • 22nd Century aims to expand its portfolio through multiple PMTA submissions across various combustible products, including filtered cigars.
  • VLN® products are the only FDA-authorized combustible cigarettes with reduced-nicotine claims, targeting ~$41 billion of the U.S. cigarette market.

The big picture

22nd Century is positioning itself as the leader in reduced-nicotine combustible cigarettes, leveraging its FDA-authorized status to expand market share. The company's strategy of pursuing multiple PMTA submissions and licensing opportunities aligns with broader industry trends toward harm reduction and regulatory compliance. With the U.S. cigarette market valued at ~$82 billion, the potential for scaling reduced-nicotine products is significant.

What we're watching

Regulatory Approval
Whether the FDA will authorize the 100mm VLN® product, expanding 22nd Century's market reach.
Market Adoption
The pace at which retailers and consumers adopt the new 100mm VLN® product.
Licensing Strategy
How effectively 22nd Century can license its reduced-nicotine technology to other tobacco companies.